Biocept Inc
BIOCDelisted Nov 20, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001044378
Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Biocept Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 29 | 29 | 0 |
| Shares | 1.90M | 1.71M | −186.1K (−9.8%) |
| Value | $1.78M | $1.57M | −$209.0K (−11.7%) |
New holders (4)
Institutions that held Biocept Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 19,715 | $18.0K | 0.00% |
| UBS Group AG | 12,356 | $11.0K | 0.00% |
| CWM, LLC | 11,200 | $10.0K | 0.00% |
| Morgan Stanley | 6 | $0 | 0.00% |
Sold out (4)
Institutions that held Biocept Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 48,164 | $45.0K |
| Virtu Financial LLC | 28,201 | $27.0K |
| Jane Street Group, LLC | 14,072 | $13.0K |
| Spire Wealth Management | 4,000 | $4.00K |